Svenja Petersohn is a Associate Research Consultant in the Modeling and Meta-Analysis team located in Pharmerit’s Rotterdam office, the Netherlands. She has experience in survival analysis, health economic modelling, uncertainty analysis and reimbursement dossiers. Svenja has therapeutic experience in the area of cardiovascular disease, oncology, ophthalmology, multiple sclerosis and others.
Prior to joining Pharmerit, Svenja worked as a PhD student and junior health economist at the Maastricht University Medical Centre+, where she was part of an Evidence Review Group for NICE and participated in the review of health-economic models and reimbursement dossiers. In January 2021, Svenja obtained her PhD from Maastricht University for her research on the economic evaluation of treatment for peripheral arterial disease. She further holds a BSc in European Public Health and a MSc in Health Sciences Research focused on HTA, both from Maastricht University. Svenja is currently a board member of the Dutch Association of young health economists (Young-NVTAG).
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.